MyStart Health logo

MyStart Health Review

7.1
★★★★☆3.6/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10

Best for: fastest compounded GLP-1 onboarding with a price lock

MyStart Health scores below our bar on medical oversight. Read the score breakdown before signing up.

Semaglutide

$299/mo · starting price

Tirzepatide

$299/mo · see plan details
Same price at every dose

Price checked on MyStart Health's site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Included

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

MyStart Health offers compounded semaglutide and tirzepatide through a program that starts at $299/month, covering clinician visits, unlimited messaging, medication, any needed blood work and shipping. A price-lock guarantee keeps your base rate the same as your dose rises. Monthly and 3-month plans are available, and the site carries a LegitScript seal.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideLegitScript Verified24/7 AccessPrice Lock Guarantee

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to MyStart Health

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
MyStart Health logo
3.6 / 5
Our editorial rating
Visit site →

from $299/mo · no insurance needed

MyStart Health at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$299/mo (starting price)
Pricing model
Flat: dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping · Labs
FDA status
1 FDA warning letter on record; see below

How we scored MyStart Health

Each dimension is scored algorithmically from MyStart Health'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.3/10

MyStart Health's headline is $299/mo. Compare it with other programs on the same plan basis. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

8.5/10

MyStart Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

8.2/10

Online intake and platform experience (ongoing clinician messaging, consult included in the price); 6 platform features disclosed.

Trust & Safety15%

5.7/10

Core details confirmed by our editors; an FDA warning letter is on file (see the regulatory notice on this page).

Accessibility10%

6.5/10

MyStart Health's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

6.8/10

Clinician messaging between visits.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this MyStart Health review

Last checked October 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$299/mo across 2 dose/plan tiers (checked October 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
An active letter is on file for this provider; see below

What to expect when you sign up with MyStart Health

We walked MyStart Health's public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Click 'Get Started' on the homepage; the site applies a SELFLOVE25 coupon code automatically.
  2. 2The intake form opens with a five-stage progress bar (Start, Preliminary, Health, Details, Eligibility).
  3. 3The first screen asks for your height and weight to calculate BMI.
Price shown before you start
  • The homepage FAQ lists a $299/month starting price before you start the quiz, but the price for your specific plan comes later.
  • Per the FAQ, payment is taken after the pre-qualification quiz and before a clinician reviews you, with a full refund in 24-48 hours if you are found ineligible.
  • The intake page shows an 'Excellent 4.7' star badge with no source; the brand's Trustpilot profile shows 4.1 from about 326 reviews.
  • Shipped orders are final: the refund policy rules out refunds or returns once medication ships.
  • A Refill Intake Form is required every 3 months on any plan.
  • Phone and email support hours are published on the site.

MyStart Health customer support

Hours
Monday-Friday 9am-7pm, Saturday 10am-4pm EST

GLP-1 medications MyStart Health offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

All-inclusive program (same base price as your dose increases)Compounded
$299/mo
semaglutide

Starts at $299/month before discounts, covering clinician visits, messaging, medication, any needed blood work and shipping. A $150 off + lifetime 25% off promo is advertised; final price shown after the quiz.

All-inclusive program (same base price as your dose increases)Compounded
$299/mo
tirzepatide

Same $299/month starting price and price lock as semaglutide. Per-drug plan prices are shown only after the health quiz.

Ready to get started?

Plans and promotions change often, so check MyStart Health's current pricing and active discounts before you decide.

See MyStart Health pricing →

What we like

  • Price Lock Guarantee: your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

Watch-outs

  • Not BBB accredited, and BBB complaints cite shipping delays and trouble reaching support
  • Compounded only: no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Once medication ships, there are no refunds or returns under any circumstances
  • Exact plan prices beyond the $299 starting rate appear only after the health quiz
  • Very new company (incorporated May 2024) with a limited track record
  • Pharmacy partners are not named, so you can't check them yourself
  • Intake page shows an unsourced 'Excellent 4.7' badge, while Trustpilot shows 4.1
  • Results claims rest on a survey of just 16 self-reporting customers

MyStart Health: built for speed, with a price lock as the hook

MyStart Health is a young, single-price GLP-1 service whose whole pitch is getting you started fast and never raising your bill. You pay $299 a month, that rate is locked even as your dose climbs, and you get semaglutide or tirzepatide in compounded form with everything bundled in. If your priority is near-instant onboarding and budget certainty, it fits. If you want a brand-name pen or a long, provable track record, it doesn't.

How the $299 flat price works

There are no dose tiers and no add-on invoices here. The single $299 monthly plan, per the company's own FAQ, covers physician evaluations, follow-up appointments, unlimited clinician messaging, your monthly prescription, a four-week or twelve-week supply of medication depending on the plan you pick, any necessary blood work, and shipping. MyStart also states your base plan amount will never increase even when your dosage goes up, though the lock excludes the first-time discount, and the exact price for your plan appears only after the health quiz. With most compounders, your cost climbs every time you titrate to a higher dose, so a rate that holds flat through escalation protects you from that climb.

The category median runs closer to $179 a month, so $299 is on the higher side of compounded pricing. You're paying a premium for the all-in bundle and the locked rate. Whether that trade is worth it depends on how much you value never getting a surprise bill as your dose ramps up.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.

The medications: compounded only

MyStart dispenses compounded semaglutide and tirzepatide under Section 503A, and to its credit it posts a clear disclosure on its landing pages stating these compounded medications are not FDA-approved and not evaluated by the FDA for safety, effectiveness, or quality. Many rivals disclose less. The flip side is that no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro is available through this provider. MyStart sells the standard weekly injections; we found no oral tirzepatide on the current site. A tablet is where SurpassMD stands out: it offers an oral semaglutide plan at one price for every dose and serves all 50 states plus DC, but it doesn't name its pharmacy.

Onboarding speed

MyStart advertises a roughly five-minute intake, a prescription turnaround inside about 24 hours, and two-to-four-day shipping. Paired with 24/7 care-team access and unlimited clinician messaging, the experience is designed to move you from sign-up to medication in your hands faster than most competitors. For someone who has already decided they want to start a GLP-1 and just wants the path of least friction, that speed is MyStart's main selling point.

  • Price-lock guarantee: your $299 base rate doesn't rise as your dose escalates
  • About a five-minute intake, ~24-hour prescription turnaround, and two-to-four-day shipping
  • Consults, follow-ups, unlimited messaging, labs, and shipping are all in the one price
  • LegitScript certified, with a clear 503A compounding disclosure on each landing page

Who runs it, and what it discloses

The legal entity is MyStart Health LLC, a Delaware management services organization that partners with licensed US clinicians. It was incorporated in May 2024, with Matthew Stern listed as founder and CEO and Dr. Ritu Chopra as chief medical advisor. On the trust side, the site carries a LegitScript seal, but the company has an FDA warning letter on file (September 2025, for selling unapproved and misbranded drugs online), covered in the regulatory notice on this page.

The gaps are about youth and disclosure. The company has been operating only since 2024, so there's little long-term track record to lean on. It is not BBB accredited, and its BBB complaints center on shipping delays and difficulty reaching support, which sits awkwardly next to the marketing emphasis on 24/7 access. Trustpilot shows about 4.1 out of 5 from roughly 326 reviews, while the intake page displays an "Excellent 4.7" badge with no source given. And the pharmacy partners aren't publicly named, which means a reader can't independently confirm the 503A compliance chain. Compare Tell Her Doc, which lists four partner pharmacies and its medical team, with injections or pills built for women, but its sales are final too. The efficacy numbers on the homepage also rest on a self-reported survey of just sixteen customers, which is far too small to treat as evidence of how well the program works. Finally, read the refund policy before you pay: once an order ships, it cannot be canceled or refunded under any circumstances, and returned medication is never accepted. You can cancel future shipments at any time by email or phone.

Who should choose it, and who should skip it

Choose MyStart Health if you want to start quickly, you value a locked-in monthly cost as you titrate up, and you're comfortable with compounded medication and a newer company. The flat $299 bundle is easy to reason about and protects you from dose-driven price creep.

Skip it if you want a brand-name GLP-1. Skip it if a company founded in 2024 with an unaccredited BBB profile and a strict no-refund-after-shipping policy gives you pause. And skip it if you want the lowest possible price, since the category median sits well below $299. Cross-check it against a couple of cheaper compounders using our scoring methodology before you commit.

Bottom line

MyStart Health sells speed and a fixed bill: fast onboarding, unlimited access, and a price lock that holds your $299 rate steady through every dose increase. It has LegitScript certification and an upfront compounding disclosure. On the other side, it's compounded-only, young, not BBB accredited, leans on a tiny efficacy survey, and refunds nothing once medication ships. If you care more about a quick start and a predictable bill than about the cheapest price or a brand-name pen, it's a credible choice you should still vet against a lower-cost alternative.

The Bottom Line

MyStart Health scores below our bar on medical oversight. Read the score breakdown before signing up.

Score: 7.1/10Best for: fastest compounded GLP-1 onboarding with a price lockFrom: $299/mo

Ready to start with MyStart Health?

From $299/mo. See current pricing and start your online intake.

MyStart Health might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want a brand-name GLP-1 such as Wegovy or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare MyStart Health vs…

MyStart Health scores7.1/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

MyStart Health (operated by MyStart Health LLC, a Delaware company) carries a LegitScript seal and publishes clear compounded-drug disclosures, noting its medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Its Chief Medical Advisor is Dr. Ritu Chopra. FDA sent MyStart Health LLC a warning letter in September 2025 over unapproved and misbranded drug sales online. It is not BBB accredited, and BBB complaints mostly cite shipping delays and difficulty reaching support. Its Trustpilot profile shows about 4.1 out of 5. MyStart was incorporated in May 2024, so it has a shorter track record than more established providers.
MyStart Health is a telehealth GLP-1 platform offering compounded semaglutide and compounded tirzepatide at a flat $299/month all-inclusive price with a price-lock guarantee. The service is built around fast onboarding: the intake takes approximately five minutes, with a targeted 24-hour prescription turnaround and 2-4 day shipping. MyStart Health operates as a Delaware medical services organization (MSO) that partners with independently licensed U.S. clinicians and third-party 503A compounding pharmacies. It holds LegitScript certification and provides 24/7 care team access with unlimited clinician messaging included in the monthly price.
MyStart Health lists compounded tirzepatide under the same $299/month starting price as its compounded semaglutide plan. That price covers physician evaluations, follow-up visits, unlimited clinician messaging, your prescription (a 4-week or 12-week supply depending on the plan), any needed blood work, and shipping. The exact price for your plan, including any first-time discount, is shown only after the health quiz. Confirm current pricing on MyStart Health's website before enrolling.
MyStart Health's price-lock guarantee means your base monthly rate does not rise as your clinician increases your dose. Most compounded GLP-1 platforms charge more at higher doses, so this matters if you stay on the program long-term. Per MyStart's FAQ: "The price of medication and ongoing care will never increase from your base plan amount, EVEN if your dosage increases in subsequent months (excluding our first-time discount)." A first-time discount is not locked in; the lock applies to the base plan price.
MyStart Health offers compounded semaglutide and compounded tirzepatide as injections. Semaglutide targets the GLP-1 receptor (the same pathway as Ozempic and Wegovy); tirzepatide targets both GLP-1 and GIP receptors (the same pathways as Zepbound and Mounjaro). Neither is an FDA-approved finished product, and MyStart discloses that these medications have not been evaluated by the FDA for safety, effectiveness, or quality. MyStart does not offer brand-name GLP-1s.
MyStart Health doesn't use public promo or coupon codes. Third-party sites advertising "MyStart Health discount codes" are typically fake; any current offer applies automatically through the link on this page.
The main red flag is an FDA warning letter on file, which this review flags. Read it before starting. We also note: Not BBB accredited, and BBB complaints cite shipping delays and trouble reaching support; compounded only: no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro; once medication ships, there are no refunds or returns under any circumstances.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

MyStart Health received an FDA warning letter dated September 9, 2025

The letter concerns unlawful sale of unapproved and misbranded drugs to United States consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this MyStart Health review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See MyStart Health's current pricing

Plans from $299/mo. Start the online intake to check eligibility and today's price.